Optimal utilization of thrombolytic therapy for acute myocardial infarction: Concepts and controversies
- 31 July 1990
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 16 (1), 223-231
- https://doi.org/10.1016/0735-1097(90)90482-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarctionJournal of the American College of Cardiology, 1989
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.Circulation, 1988
- Thrombolytic therapy of acute myocardial infarction: Emerging challenges of implementationJournal of the American College of Cardiology, 1987
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- What proportion of patients with myocardial infarction are suitable for thrombolysis?Heart, 1987
- A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): Long-term mortality and morbidityJournal of the American College of Cardiology, 1987
- Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survivalJournal of the American College of Cardiology, 1986
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intracoronary Fibrinolytic Therapy in Acute Myocardial InfarctionNew England Journal of Medicine, 1983